Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000409287 | SCV000488902 | likely benign | Paragangliomas 4 | 2016-07-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001571908 | SCV001796465 | likely benign | not provided | 2020-07-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30877234) |
Labcorp Genetics |
RCV002058845 | SCV002434785 | likely benign | Gastrointestinal stromal tumor; Paragangliomas 4; Pheochromocytoma | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268039 | SCV002552534 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022151 | SCV004944677 | likely benign | Hereditary cancer-predisposing syndrome | 2023-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |